IRVINE, Calif.--(BUSINESS WIRE)--Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Zimmer Biomet Holdings, Inc. (“Zimmer Biomet” or the “Company”) (NYSE: ZBH) concerning possible violations of federal securities laws.
If you purchased shares of Zimmer Biomet and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
The investigation concentrates on whether Zimmer Biomet and certain of its officers and/or directors violated federal securities laws. On October 31, 2016, the Company announced that it was lowering its full-year forecast, to a lower revenue expectation than analysts predicted.
If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
This press release may constitute Attorney Advertising in some jurisdictions.
